A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC

Clinical trial NCT04331743 · UNKNOWN

Trial details

NCT number: NCT04331743
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2021-06-05
Primary completion: 2023-05-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.